Skip to main content

Table 2 Changes in the prevalence of abnormal haematological parameters

From: Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study

Characteristic N = 337

Baseline no (%)

6 months after initiation of HAART no (%)

Relative risk (95 % CI)

P value

Hb <10 g/dl

121 (35.9)

56 (16.6)

0.56 (0.44, 0.70)

<0.0001

MCV <70 fl

104 (31.0)

28 (8.3)

0.37 (0.27, 0.52)

<0.0001

MCH <24 pg

154 (46.7)

49 (14.6)

0.45 (0.35, 0.59)

<0.0001

Platelets <150,000

67 (20.0)

22 (6.5)

0.46 (0.32, 0.66)

<0.0001

WBC <11,000

33 (10.0)

21 (6.2)

0.76 (0.54, 1.08)

0.09

Granulocytes <1000

22 (6.5)

52 (16)

1.48 (1.25, 1.75)

<0.0001